These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 2707924)

  • 1. Pharmacokinetics of ciprofloxacin in impaired liver function.
    Esposito S; Miniero M; Barba D; Sagnelli E
    Int J Clin Pharmacol Res; 1989; 9(1):37-41. PubMed ID: 2707924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single and repeated dose pharmacokinetics of dexketoprofen trometamol in patients with impaired liver function.
    Valles J; Artigas R; Bertolotti M; Crea A; Muller F; Paredes I; Capriati A
    Methods Find Exp Clin Pharmacol; 2006 Jun; 28 Suppl A():29-36. PubMed ID: 16801990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single and multiple dose pharmacokinetics of oral ciprofloxacin in elderly patients.
    Guay DR; Awni WM; Peterson PK; Obaid S; Stein D; Breitenbucher R; Matzke GR
    Int J Clin Pharmacol Ther Toxicol; 1988 Jun; 26(6):279-84. PubMed ID: 3410603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ciprofloxacin concentrations in human fluids and tissues following a single oral dose.
    Esposito S; Galante D; Barba D; D'Errico G; Mazzone A; Montanaro S
    Int J Clin Pharmacol Res; 1987; 7(3):181-6. PubMed ID: 3596861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of ciprofloxacin in subjects with varying degrees of renal function and undergoing hemodialysis or CAPD.
    Kowalsky SF; Echols M; Schwartz MT; Bailie GR; McCormick E
    Clin Nephrol; 1993 Jan; 39(1):53-8. PubMed ID: 8428409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of E5564, a lipopolysaccharide antagonist, in patients with impaired hepatic function.
    Liang E; Wong YN; Allen I; Kao R; Marino M; DiLea C
    J Clin Pharmacol; 2003 Dec; 43(12):1361-9. PubMed ID: 14615472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single dose pharmacokinetics of manidipine in hepatic impaired patients and healthy controls.
    Deroubaix X; Lins RL; Lens S; Allemon A; Jeanbaptiste B; Poli G; Acerbi D; Stockis A; Ventura P
    Int J Clin Pharmacol Ther; 1998 Jul; 36(7):386-91. PubMed ID: 9707354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of levetiracetam in patients with moderate to severe liver cirrhosis (Child-Pugh classes A, B, and C): characterization by dynamic liver function tests.
    Brockmöller J; Thomsen T; Wittstock M; Coupez R; Lochs H; Roots I
    Clin Pharmacol Ther; 2005 Jun; 77(6):529-41. PubMed ID: 15961984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of age on the pharmacokinetics of naftidrofuryl after single oral administration in elderly versus young healthy volunteers.
    Hulot T; Gamand S; Dupain T; Ahtoy P; Bromet M
    Arzneimittelforschung; 1998 Sep; 48(9):900-4. PubMed ID: 9793615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of oral lidocaine and nifedipine in patients with liver cirrhosis.
    Tonsuwannont W; Praisontarangkul OA; Manorot M; Klangwarnwong D
    J Med Assoc Thai; 1996 May; 79(5):309-19. PubMed ID: 8708523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and safety of single oral doses of amlodipine in patients with and without hepatic impairment: an open study.
    Darnis F; Poupon R
    Int J Clin Pharmacol Res; 1993; 13(1):29-33. PubMed ID: 8509234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population pharmacokinetics of ciprofloxacin in patients with liver impairments analyzed by NPEM2 algorithm--a retrospective study.
    Terziivanov D; Atanasova I; Dimitrova V
    Int J Clin Pharmacol Ther; 1998 Jul; 36(7):376-82. PubMed ID: 9707352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ciprofloxacin prolonged-release tablets do not affect warfarin pharmacokinetics and pharmacodynamics.
    Washington C; Hou SY; Hughes NC; Campanella C; Berner B
    J Clin Pharmacol; 2007 Oct; 47(10):1320-6. PubMed ID: 17724088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of ciprofloxacin in acutely ill and convalescent elderly patients.
    Guay DR; Awni WM; Peterson PK; Obaid S; Breitenbucher R; Matzke GR
    Am J Med; 1987 Apr; 82(4A):124-9. PubMed ID: 3578321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex-related differences in the pharmacokinetics of oral ciprofloxacin.
    Overholser BR; Kays MB; Forrest A; Sowinski KM
    J Clin Pharmacol; 2004 Sep; 44(9):1012-22. PubMed ID: 15317829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of ciprofloxacin in patients with liver cirrhosis.
    Dixit RK; Satapathy SK; Kumar R; Dhiman RK; Garg SK; Taneja S; Bhargava VK; Chawla YK
    Indian J Gastroenterol; 2002; 21(2):62-3. PubMed ID: 11990328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetics and tolerability of telenzepine in patients with compensated liver cirrhosis].
    Reinicke A; Müller P; Dammann HG; Simon B
    Arzneimittelforschung; 1990 Nov; 40(11):1239-41. PubMed ID: 2085337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of cirrhosis on the steady-state pharmacokinetics of oral ciprofloxacin.
    Frost RW; Lettieri JT; Krol G; Shamblen EC; Lasseter KC
    Clin Pharmacol Ther; 1989 Jun; 45(6):608-16. PubMed ID: 2731404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of ciprofloxacin in liver cirrhosis.
    Ruhnke M; Trautmann M; Borner K; Hopfenmüller W
    Chemotherapy; 1990; 36(6):385-91. PubMed ID: 2292201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of pitavastatin in subjects with Child-Pugh A and B cirrhosis.
    Hui CK; Cheung BM; Lau GK
    Br J Clin Pharmacol; 2005 Mar; 59(3):291-7. PubMed ID: 15752374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.